T. Rowe Price Associates
ARTC

T. Rowe Price Associates’s ARTHROCARE CORP ARTC Stock Holding History

T. Rowe Price Associates’s Portfolio ARTC Stock Details ARTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-428,056
Closed -$17.2M – 2544
2013
Q4 		$17.2M Sell
428,056
-318,931
-43% -$11.8M ﹤0.01% 1139
2013
Q3 		$26.6M Buy
746,987
+700
+0.1% +$24.4K 0.01% 1004
2013
Q2 		$25.8M Buy
+746,287
New +$25.7M 0.01% 997

Other funds holding ARTC

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates's ARTC Position: Q1 2014 in Review

T. Rowe Price Associates sold out of ARTHROCARE CORP (ARTC) in Q1 2014, closing a stake of 428,056 shares — an estimated $17.2M sold.

T. Rowe Price Associates first reported a position in ARTC in Q2 2013 and held it in 3 quarters. The position peaked at $26.6M in Q3 2013. 117 funds tracked by Wall St. Rank hold ARTC as of Q1 2014.

  • T. Rowe Price Associates reported no remaining ARTHROCARE CORP position as of Q1 2014 after selling out during the quarter.
  • T. Rowe Price Associates sold 428,056 ARTHROCARE CORP shares in Q1 2014, an estimated $17.2M.
  • T. Rowe Price Associates first reported a position in ARTHROCARE CORP in Q2 2013 and held it in 3 quarters.
  • T. Rowe Price Associates's ARTHROCARE CORP position peaked at $26.6M in Q3 2013.
  • 117 funds tracked by Wall St. Rank held ARTHROCARE CORP as of Q1 2014.

Based on T. Rowe Price Associates's 13F filing for Q1 2014, filed 15 May 2014.